DT Cloud Star Acquisition Corporation /
PrimeGen US, Inc.
PrimeGen US and DT Cloud Star agree to business combination
Source for the buyer and target: DT Cloud Star Acquisition Corp
For the buyer and target.
“PrimeGen US, Inc. (“PrimeGen US” or the “Company”), a pioneering biotech company advancing innovative stem cell and exosome therapies, today announced it has entered into a definitive business combination agreement dated as of February 2, 2026 (the “Business Combination Agreement”) with DT Cloud Star Acquisition Corporation (“DT Cloud Star”), a publicly traded special purpose acquisition company (Nasdaq: DTSQ).”
Published 4 Feb 2026
Open the sourceWhat happened
PrimeGen US, Inc. and DT Cloud Star Acquisition Corporation entered into a business combination agreement dated Feb. 2, 2026. The transaction implies an equity value of approximately $1.5 billion. [01]
PrimeGen US advances stem cell and exosome therapies. [01]
The source
Everything on this page comes from the source below, quoted word for word.
PrimeGen US and DT Cloud Star agree to business combination
This document is the source for the companies, stage, figure and people on this page.
Open the sourceTimeline
Every date the source states, in order, each with the words it comes from. Anything marked ahead is a target the source gives, not something that has happened.
Announced
“PrimeGen US and DT Cloud Star agree to business combination PrimeGen US, Inc. and DT Cloud Star Acquisition Corporation entered into a business combination agreement dated Feb. 2, 2026”
Open the source
The same firms, in other deals
The firms' deal history and connections across other deals.
These firms' full profiles are part of Pro.
Get ProAlready a member? Sign in
Pro is open to everyone.
By email · Weekly